Background Evidence on the risk of cardiovascular disease (CVD) and CVD risk factors in people with HIV (PWH) is limited. We aimed to identify the risk of composite CVD, individual CVD events and common risk factors. Methods This was a nationwide population-based cohort study comparing adult (≥18y) PWH with HIV-negative individuals matched on age, sex, ethnicity and location. The primary outcome was composite CVD comprising stroke, myocardial infarction (MI), peripheral vascular disease (PVD), ischaemic heart disease and heart failure. The secondary outcomes were individual CVD events, hypertension, diabetes, chronic kidney disease (CKD) and all-cause mortality. Cox proportional hazard regression models were used to examine the risk of...
After the successful introduction of highly active antiretroviral agents the survival of patients in...
Background: CVD is the leading cause of death in PLWH. HIV positive individuals have a 1.5-2-fold gr...
AIMS: HIV-infected patients receiving combination antiretroviral therapy may experience metabolic co...
BACKGROUND Evidence on the risk of cardiovascular disease (CVD) and CVD risk factors in people wi...
BACKGROUND Evidence on the risk of cardiovascular disease (CVD) and CVD risk factors in people wi...
BackgroundEvidence on the risk of cardiovascular disease (CVD) and CVD risk factors in people with h...
Background HIV infection is associated with increased risk of cardiovascular disease (CVD) in men. W...
Objective Cardiovascular disease (CVD) is one of the leading non-AIDS-defining causes of death among...
Human immunodeficiency virus (HIV) infection represents a major cardiovascular risk factor, and the ...
Abstract People living with HIV (PLWH) have a two‐fold higher risk of cardiovascular diseases (CVDs)...
BackgroundHIV infection is associated with increased risk of cardiovascular disease (CVD) in men. Wh...
Cardiovascular disease, and particularly coronary heart disease, is an emerging area of concern in t...
Introduction: cardiovascular risk factors are prevalent in HIV-positive patients which places them a...
Matthew Law10 on behalf of the D:A:D study group Background: With the aging of the population living...
AIMS: HIV-infected patients receiving combination antiretroviral therapy may experience metabolic c...
After the successful introduction of highly active antiretroviral agents the survival of patients in...
Background: CVD is the leading cause of death in PLWH. HIV positive individuals have a 1.5-2-fold gr...
AIMS: HIV-infected patients receiving combination antiretroviral therapy may experience metabolic co...
BACKGROUND Evidence on the risk of cardiovascular disease (CVD) and CVD risk factors in people wi...
BACKGROUND Evidence on the risk of cardiovascular disease (CVD) and CVD risk factors in people wi...
BackgroundEvidence on the risk of cardiovascular disease (CVD) and CVD risk factors in people with h...
Background HIV infection is associated with increased risk of cardiovascular disease (CVD) in men. W...
Objective Cardiovascular disease (CVD) is one of the leading non-AIDS-defining causes of death among...
Human immunodeficiency virus (HIV) infection represents a major cardiovascular risk factor, and the ...
Abstract People living with HIV (PLWH) have a two‐fold higher risk of cardiovascular diseases (CVDs)...
BackgroundHIV infection is associated with increased risk of cardiovascular disease (CVD) in men. Wh...
Cardiovascular disease, and particularly coronary heart disease, is an emerging area of concern in t...
Introduction: cardiovascular risk factors are prevalent in HIV-positive patients which places them a...
Matthew Law10 on behalf of the D:A:D study group Background: With the aging of the population living...
AIMS: HIV-infected patients receiving combination antiretroviral therapy may experience metabolic c...
After the successful introduction of highly active antiretroviral agents the survival of patients in...
Background: CVD is the leading cause of death in PLWH. HIV positive individuals have a 1.5-2-fold gr...
AIMS: HIV-infected patients receiving combination antiretroviral therapy may experience metabolic co...